|
Tweet | ||
345 * | Tue, 8/11/2015, 10:30 AM - 12:20 PM | CC-619 | |
Some Challenges and Advances in Heterogeneous Treatment Effect Evaluation and Trial Design Considerations — Topic Contributed Papers | |||
Biopharmaceutical Section , Biometrics Section | |||
Organizer(s): Mike Shi, Takeda Pharmaceuticals | |||
Chair(s): Guoliang 'Charlie' Cao, Takeda Pharmaceuticals | |||
10:35 AM | Repeated Measures vs. Crossover: Selecting an Optimal Design for a Pivotal Trial — Theodore Lystig, Medtronic, Inc. | ||
10:55 AM | Detecting Outlying Trials in Network Meta-Analysis — Jing Zhang, University of Maryland ; Haoda Fu, Eli Lilly and Company ; Bradley P. Carlin, University of Minnesota | ||
11:15 AM | Challenges of Psychiatric Clinical Trials: Methods to Mitigate Placebo Responses — Mike Shi, Takeda Pharmaceuticals ; Wei Zhong, Takeda Pharmaceuticals | ||
11:35 AM | Systemic Utilization of Phase II Interim Efficacy Analysis to Expedite Drug Development — Jie Huang, Genentech, Inc./Roche | ||
11:55 AM | Assessing Consistency of Treatment Effect in Multiregional Clinical Trials — Bin Zhang, Millennium Pharmaceutical, Inc. ; Zhaoyang Teng, Takeda Pharmaceutical International Co. ; Jing Wang, Gilead Sciences | ||
12:15 PM | Floor Discussion |
For program information, contact the JSM Registration Department or phone (888) 231-3473.
For Professional Development information, contact the Education Department.
The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.
2015 JSM Online Program Home
ASA Meetings Department
732 North Washington Street, Alexandria, VA 22314
(703) 684-1221 • meetings@amstat.org
Copyright © American Statistical Association.